158 related articles for article (PubMed ID: 12599012)
1. A comparison of the biodistribution and biokinetics of (99m)Tc-anti-CD66 mAb BW 250/183 and (99m)Tc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy.
Buchmann I; Kull T; Glatting G; Bunjes D; Hale G; Kotzerke J; Rattat D; Dohner H; Reske SN
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):667-73. PubMed ID: 12599012
[TBL] [Abstract][Full Text] [Related]
2. Myeloablative radioimmunotherapy with Re-188-anti-CD66-antibody for conditioning of high-risk leukemia patients prior to stem cell transplantation: biodistribution, biokinetics and immediate toxicities.
Buchmann I; Bunjes D; Kotzerke J; Martin H; Glatting G; Seitz U; Rattat D; Buck A; Döhner H; Reske SN
Cancer Biother Radiopharm; 2002 Apr; 17(2):151-63. PubMed ID: 12030109
[TBL] [Abstract][Full Text] [Related]
3. [Kinetics and dosimetry of monoclonal antibody MAb-170: evaluation of possibilities for intraperitoneal radioimmunotherapy].
Alexander C; Holländer M; Schmidt W; Kirsch CM
Nuklearmedizin; 2001 Dec; 40(6):207-14. PubMed ID: 11797509
[TBL] [Abstract][Full Text] [Related]
4. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice.
Elgqvist J; Bernhardt P; Hultborn R; Jensen H; Karlsson B; Lindegren S; Warnhammar E; Jacobsson L
J Nucl Med; 2005 Mar; 46(3):464-71. PubMed ID: 15750160
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and kinetics of (131)I-labelled anti-CD20 MAB IDEC-C2B8 (rituximab) in relapsed non-Hodgkin's lymphoma.
Scheidhauer K; Wolf I; Baumgartl HJ; Von Schilling C; Schmidt B; Reidel G; Peschel C; Schwaiger M
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1276-82. PubMed ID: 12271407
[TBL] [Abstract][Full Text] [Related]
6. Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemia.
Neumaier B; Mottaghy FM; Buck AK; Glatting G; Blumstein NM; Mahren B; Vogg AT; Reske SN
Cancer Biother Radiopharm; 2008 Dec; 23(6):819-24. PubMed ID: 19111052
[TBL] [Abstract][Full Text] [Related]
7. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
[TBL] [Abstract][Full Text] [Related]
8. Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients.
Cremonesi M; Ferrari M; Chinol M; Stabin MG; Grana C; Prisco G; Robertson C; Tosi G; Paganelli G
Eur J Nucl Med; 1999 Feb; 26(2):110-20. PubMed ID: 9933344
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunotherapy for the intensification of conditioning before stem cell transplantation: differences in dosimetry and biokinetics of 188Re- and 99mTc-labeled anti-NCA-95 MAbs.
Kotzerke J; Glatting G; Seitz U; Rentschler M; Neumaier B; Bunjes D; Duncker C; Dohr D; Bergmann L; Reske SN
J Nucl Med; 2000 Mar; 41(3):531-7. PubMed ID: 10716329
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia.
Seitz U; Neumaier B; Glatting G; Kotzerke J; Bunjes D; Reske SN
Eur J Nucl Med; 1999 Oct; 26(10):1265-73. PubMed ID: 10541824
[TBL] [Abstract][Full Text] [Related]
11. Physiologically Based Pharmacokinetic Modeling Is Essential in 90Y-Labeled Anti-CD66 Radioimmunotherapy.
Kletting P; Maaß C; Reske S; Beer AJ; Glatting G
PLoS One; 2015; 10(5):e0127934. PubMed ID: 26010360
[TBL] [Abstract][Full Text] [Related]
12. Safety, pharmacokinetic and dosimetry evaluation of the proposed thrombus imaging agent 99mTc-DI-DD-3B6/22-80B3 Fab'.
Macfarlane DJ; Smart RC; Tsui WW; Gerometta M; Eisenberg PR; Scott AM
Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):648-56. PubMed ID: 16528525
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of 99mTc-labeled interleukin-8 in experimental inflammation and infection.
Rennen HJ; Boerman OC; Oyen WJ; Corstens FH
J Nucl Med; 2003 Sep; 44(9):1502-9. PubMed ID: 12960199
[TBL] [Abstract][Full Text] [Related]
14. Myeloablative radioimmunotherapy in conditioning prior to haematological stem cell transplantation: closing the gap between benefit and toxicity?
Buchmann I; Meyer RG; Mier W; Haberkorn U
Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):484-98. PubMed ID: 19130053
[TBL] [Abstract][Full Text] [Related]
15. Dependence of the anti-CD66 antibody biodistribution on the dissociation constant: a simulation study.
Kletting P; Reske SN; Glatting G
Z Med Phys; 2011 Dec; 21(4):301-4. PubMed ID: 21530196
[TBL] [Abstract][Full Text] [Related]
16. α-Imaging Confirmed Efficient Targeting of CD45-Positive Cells After 211At-Radioimmunotherapy for Hematopoietic Cell Transplantation.
Frost SH; Miller BW; Bäck TA; Santos EB; Hamlin DK; Knoblaugh SE; Frayo SL; Kenoyer AL; Storb R; Press OW; Wilbur DS; Pagel JM; Sandmaier BM
J Nucl Med; 2015 Nov; 56(11):1766-73. PubMed ID: 26338894
[TBL] [Abstract][Full Text] [Related]
17. Modelling radioimmunotherapy with anti-CD45 antibody to obtain a more favourable biodistribution.
Kiraly F; Kletting P; Reske S; Glatting G
Nuklearmedizin; 2009; 48(3):113-9. PubMed ID: 19322499
[TBL] [Abstract][Full Text] [Related]
18. Radioimmuno targetting (99m)technetium labeled anti-epidermal growth factor receptor monoclonal antibodies in experimental tumor models.
Meenakshi A; Ganesh V; Suresh Kumar R; Siva Kumar N
Q J Nucl Med; 2003 Jun; 47(2):139-44. PubMed ID: 12865874
[TBL] [Abstract][Full Text] [Related]
19. Dosimetry with (188)Re-labelled monoclonal anti-CD66 antibodies. A simplified approach based on a single measurement 3 h p.i.
Glatting G; Kull T; Blumstein NM; Bunjes D; Neumaier B; Buck AK; Reske SN
Nuklearmedizin; 2006; 45(3):134-8. PubMed ID: 16710510
[TBL] [Abstract][Full Text] [Related]
20. (99m)Tc-labeled murine ior C5 monoclonal antibody in colorectal carcinoma patients: pharmacokinetics, biodistribution, absorbed radiation doses to normal organs and tissues and tumor localization.
Iznaga-Escobar N; Ramos-Suzarte M; Morales-Morales A; Torres-Arocha L; Rodríguez-Mesa N; Pérez-Rodriguez R
Methods Find Exp Clin Pharmacol; 2004 Nov; 26(9):687-96. PubMed ID: 15632954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
